Healthcare Spending vs. Health Investment: A Critical Gap
A physician examines why insurers rarely invest in chronic illness prevention, citing a structural mismatch in how healthcare savings are realized.
A fundamental tension in the American healthcare system pits short-term insurance economics against long-term patient wellness, according to an analysis by Russell Greenfield, MD, highlighted in a new piece from Whittier, California.
At the core of the issue is a timing problem: an insurer that funds a prevention program designed to reduce chronic illness may never recoup those savings if enrolled members switch to a competing plan before the health benefits — and the associated cost reductions — take hold. The financial incentive to invest in prevention effectively evaporates under that dynamic.
Read more 1031 Specialists to Appear on National PBS Show About Tax Strategy →
The structural misalignment means healthcare dollars flow heavily toward treatment rather than prevention, even when earlier intervention is widely understood to be more cost-effective over time. Greenfield's examination suggests the system is calibrated to pay for illness, not to invest in its absence.
This gap between spending and genuine health investment raises broader questions about how insurers, employers, and policymakers design and fund wellness programs. Without mechanisms that allow prevention-focused investors to capture downstream savings, the incentive gap is likely to persist regardless of clinical evidence supporting preventive care.
The analysis arrives as healthcare costs remain a central concern for American households and businesses alike, adding analytical weight to ongoing debates about how the system should be restructured to reward outcomes over volume. Continue reading at All Financial Services & Investing.